MAM
RIGL icon

Meeder Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Meeder Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-301
Closed -$11K – 2084
2021
Q3 		$11K Hold
301
– – ﹤0.01% 1631
2021
Q2 		$13K Sell
301
-251
-45% -$9.48K ﹤0.01% 1613
2021
Q1 		$19K Buy
+552
New +$21.9K ﹤0.01% 1422
2020
Q4 		– Sell
-2,238
Closed -$54K – 2156
2020
Q3 		$54K Hold
2,238
– – ﹤0.01% 944
2020
Q2 		$40K Hold
2,238
– – ﹤0.01% 973
2020
Q1 		$35K Sell
2,238
-4,358
-66% -$92.8K ﹤0.01% 1042
2019
Q4 		$141K Buy
6,596
+2,911
+79% +$59.9K 0.01% 700
2019
Q3 		$68K Buy
3,685
+3,536
+2,373% +$73.1K ﹤0.01% 914
2019
Q2 		$4K Buy
149
+14
+10% +$316 ﹤0.01% 1733
2019
Q1 		$3K Hold
135
– – ﹤0.01% 1508
2018
Q4 		$3K Buy
135
+12
+10% +$339 ﹤0.01% 1523
2018
Q3 		$4K Buy
123
+68
+124% +$2.04K ﹤0.01% 1374
2018
Q2 		$1.55K Hold
55
– – ﹤0.01% 1447
2018
Q1 		$2K Sell
55
-54
-50% -$2.16K ﹤0.01% 1391
2017
Q4 		$5K Buy
+109
New +$4.15K ﹤0.01% 1322
2017
Q3 		– Sell
-137
Closed -$4K – 1739
2017
Q2 		$4K Hold
137
– – ﹤0.01% 1268
2017
Q1 		$5K Sell
137
-142
-51% -$3.62K ﹤0.01% 1086
2016
Q4 		$7K Buy
+279
New +$7.99K ﹤0.01% 815

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Meeder Asset Management's RIGL Position: Q4 2021 in Review

Meeder Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2021, closing a stake of 301 shares — an estimated $11K sold.

Meeder Asset Management first reported a position in RIGL in Q4 2016 and held it in 18 quarters. The position peaked at $141K in Q4 2019. 162 funds tracked by Wall St. Rank hold RIGL as of Q4 2021.

  • Meeder Asset Management reported no remaining Rigel Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 301 Rigel Pharmaceuticals shares in Q4 2021, an estimated $11K.
  • Meeder Asset Management first reported a position in Rigel Pharmaceuticals in Q4 2016 and held it in 18 quarters.
  • Meeder Asset Management's Rigel Pharmaceuticals position peaked at $141K in Q4 2019.
  • 162 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.